← Open Payments lookup

KELLIE WYDRINSKI: Open Payments

NPI 1184471377 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,426 in 23 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $676 · 2025 $1,426

Food & beverage: $1,426
CompanyPaymentsAmount
Janssen Biotech, Inc.5$392
Mallinckrodt Hospital Products Inc.5$190
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$168
Madrigal Pharmaceuticals1$141
Regeneron Healthcare Solutions, Inc.2$135
Gilead Sciences, Inc.1$119
Ardelyx, Inc.1$116
Ipsen Biopharmaceuticals, Inc1$66
Takeda Pharmaceuticals U.S.A., Inc.3$60
Daiichi Sankyo Inc.1$20

Products named: TREMFYA, TERLIVAZ, XIFAXAN, REZDIFFRA, Livdelzi, IBSRELA, IQIRVO, ENTYVIO.

Industry payments across GA — which companies pay providers there.